We are live on ! Find out more
ESPR

Esperion Therapeutics
ESPR

Delisted

ESPR was delisted on the 10th of July, 2026.

188 hedge funds and large institutions have $286M invested in Esperion Therapeutics in 2025 Q3 according to their latest regulatory filings, with 48 funds opening new positions, 56 increasing their positions, 37 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

196% more capital invested

Capital invested by funds: $96.6M → $286M (+$189M)

140% more first-time investments, than exits

New positions opened: 48 | Existing positions closed: 20

51% more repeat investments, than reductions

Existing positions increased: 56 | Existing positions reduced: 37

15% more funds holding

Funds holding: 163188 (+25)

4% more ownership

Funds ownership: 49.55%53.55% (+4%)

9% more call options, than puts

Call options by funds: $3.25M | Put options by funds: $2.99M

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

Holders
188
Holders Change
+25
Holders Change %
+15.34%
% of All Funds
2.47%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.01%
New
48
Increased
56
Reduced
37
Closed
20
Calls
$3.25M
Puts
$2.99M
Net Calls
+$257K
Net Calls Change
+$783K
Name Holding Trade Value Shares
Change
Change in
Stake
BBI
201
Baxter Bros Inc
Connecticut
-$9.84K -10,000 Closed
WAP
202
Wealthcare Advisory Partners
Pennsylvania
-$9.84K -10,000 Closed
RBI
203
Raiffeisen Bank International
Austria
-$8.51K -4,400 Closed
National Bank of Canada
204
National Bank of Canada
Quebec, Canada
-$2.27K -2,300 Closed
BC
205
Barrett & Company
Rhode Island
-$295 -300 Closed
TCOV
206
Trust Company of Vermont
Vermont
-$295 -300 Closed
SS
207
Sunbelt Securities
Texas
-$220 -100 Closed